21559013|increase|C0442805|start=3|end=11|CONC
21559013|cancer stem cell|C1956422|start=15|end=31|ANAT
21559013|population|C0032659|start=32|end=42|CONC
21559013|primary|C0205225^C0439631|start=49|end=56|PROC^CONC
21559013|systemic therapy|C1515119|start=57|end=73|PROC
21559013|is a|C1292718|start=74|end=78|CONC
21559013|poor|C1561558^C2700379^C1561559^C0542537^C0032854^C1547310|start=79|end=83|CONC
21559013|prognostic factor|C1514474|start=84|end=101|PHYS
21559013|breast cancer|C0006142^C0678222|start=105|end=118|DISO
21559013|background|C1706907|start=120|end=130|CONC
21559013|cancer stem cell|C1956422|start=136|end=152|ANAT
21559013|hypothesis|C1512571|start=159|end=169|CONC
21559013|clinical|C1611832^C1555900^C1608518^C3272565^C0205210|start=184|end=192|CONC
21559013|cancer|C0006826^C1547140^C1306459^C2707253|start=210|end=216|DISO^OCCU^PHYS
21559013|therapeutics|C0039796|start=217|end=229|PROC
21559013|proposed|C1553874^C1578820|start=245|end=253|CONC
21559013|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=254|end=258|ACTI^CONC
21559013|aim|C0279214^C1947946^C3540471^C1413231^C3540472|start=291|end=294|PROC^GENE^CONC
21559013|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=303|end=308|PROC^OBJC^CONC
21559013|investigate|C1292732|start=316|end=327|CONC
21559013|changes|C0392747^C0443172|start=328|end=335|CONC
21559013|populations|C0032659|start=347|end=358|CONC
21559013|primary|C0205225^C0439631|start=376|end=383|PROC^CONC
21559013|systemic therapy|C1515119|start=384|end=400|PROC
21559013|pst|C1539876^C3813590^C1152487|start=402|end=405|GENE^PHYS
21559013|prognostic|C0220901|start=417|end=427|CONC
21559013|role|C1705809^C0035820^C1705812^C1704326^C1705811^C1705810|start=428|end=432|ACTI^CONC
21559013|breast cancer|C0006142^C0678222|start=442|end=455|DISO
21559013|methods|C0025664^C0449851^C0025663|start=457|end=464|CONC
21559013|paired|C1709450|start=466|end=472|CONC
21559013|pst|C1539876^C3813590^C1152487|start=499|end=502|GENE^PHYS
21559013|breast cancer|C0006142^C0678222|start=507|end=520|DISO
21559013|tissue|C0040300^C1547928|start=521|end=527|ANAT^CONC
21559013|obtained|C1301820|start=533|end=541|CONC
21559013|clinical stage ii|C0205571|start=547|end=564|CONC
21559013|iii|C0439070^C1705160|start=568|end=571|CONC
21559013|pst|C1539876^C3813590^C1152487|start=599|end=602|GENE^PHYS
21559013|regimen|C0040808^C2945654|start=612|end=619|PROC^CONC
21559013|plus|C0332287|start=635|end=639|CONC
21559013|plus|C0332287|start=677|end=681|CONC
21559013|subsequent|C0332282|start=715|end=725|CONC
21559013|breast|C0006141^C1268990|start=726|end=732|ANAT
21559013|resection|C0015252^C0728940|start=733|end=742|PROC
21559013|cd44|C1332712|start=782|end=786|GENE
21559013|cd24|C1413212|start=788|end=792|GENE
21559013|aldehyde dehydrogenase 1|C1412333|start=797|end=821|GENE
21559013|aldh1|C1412333|start=824|end=829|GENE
21559013|phenotypes|C0031437|start=832|end=842|PHYS
21559013|determined by|C0521095|start=848|end=861|CONC
21559013|immunohistochemistry|C0021044|start=862|end=882|PROC
21559013|proportion|C1709707|start=902|end=912|CONC
21559013|cd44|C1332712|start=916|end=920|GENE
21559013|cd24|C1413212|start=922|end=926|GENE
21559013|tumour cells|C0431085|start=928|end=940|ANAT
21559013|aldh1|C1412333|start=945|end=950|GENE
21559013|pre|C2257086^C0332152^C0740175|start=965|end=968|PHYS^CONC
21559013|chemotherapy|C0392920^C3665472^C0013217|start=969|end=981|PROC^CONC
21559013|tissue|C0040300^C1547928|start=982|end=988|ANAT^CONC
21559013|correlated|C1707520|start=993|end=1003|CONC
21559013|histologic grade|C0919553|start=1016|end=1032|CONC
21559013|oestrogen receptor|C3811131|start=1034|end=1052|PROC
21559013|high|C2700149^C1561957^C0205250^C1299351^C1561958|start=1070|end=1074|CONC
21559013|proliferation index|C1514489^C0812425|start=1081|end=1100|PHEN^CONC
21559013|basal|C0205112|start=1105|end=1110|CONC
21559013|subtype|C0449560|start=1116|end=1123|CONC
21559013|breast cancer|C0006142^C0678222|start=1127|end=1140|DISO
21559013|aldehyde dehydrogenase 1|C1412333|start=1142|end=1166|GENE
21559013|pre|C2257086^C0332152^C0740175|start=1181|end=1184|PHYS^CONC
21559013|chemotherapy|C0392920^C3665472^C0013217|start=1185|end=1197|PROC^CONC
21559013|biopsy|C0220797^C1546569^C1548825^C1706430^C0005558|start=1198|end=1204|PROC^CONC
21559013|associated with|C0332281|start=1214|end=1229|CONC
21559013|rate|C1521828^C0871208^C1549480|start=1239|end=1243|ACTI^CONC
21559013|pathologic|C1521733|start=1247|end=1257|CONC
21559013|complete|C1548561^C0205197^C1706059|start=1258|end=1266|CONC
21559013|response|C2911692^C1706817^C0871261|start=1267|end=1275|PHYS^CONC
21559013|following|C0332282|start=1276|end=1285|CONC
21559013|pst|C1539876^C3813590^C1152487|start=1286|end=1289|GENE^PHYS
21559013|populations|C0032659|start=1322|end=1333|CONC
21559013|pst|C1539876^C3813590^C1152487|start=1351|end=1354|GENE^PHYS
21559013|cd44|C1332712|start=1375|end=1379|GENE
21559013|cd24|C1413212|start=1381|end=1385|GENE
21559013|aldh1|C1412333|start=1391|end=1396|GENE
21559013|tumour cells|C0431085|start=1398|end=1410|ANAT
21559013|increased|C0442805^C0205217|start=1430|end=1439|CONC
21559013|pst|C1539876^C3813590^C1152487|start=1446|end=1449|GENE^PHYS
21559013|cases|C1533148^C0868928|start=1455|end=1460|CONC
21559013|increased|C0442805^C0205217|start=1466|end=1475|CONC
21559013|cd44|C1332712|start=1476|end=1480|GENE
21559013|cd24|C1413212|start=1482|end=1486|GENE
21559013|tumour cell|C0431085|start=1488|end=1499|ANAT
21559013|populations|C0032659|start=1500|end=1511|CONC
21559013|pst|C1539876^C3813590^C1152487|start=1518|end=1521|GENE^PHYS
21559013|high|C2700149^C1561957^C0205250^C1299351^C1561958|start=1529|end=1533|CONC
21559013|proliferation index|C1514489^C0812425|start=1540|end=1559|PHEN^CONC
21559013|post-chemotherapy|C0439577|start=1563|end=1580|CONC
21559013|specimens|C0370003|start=1581|end=1590|OBJC
21559013|increased|C0442805^C0205217|start=1606|end=1615|CONC
21559013|aldh1|C1412333|start=1616|end=1621|GENE
21559013|tumour cell|C0431085|start=1623|end=1634|ANAT
21559013|population|C0032659|start=1635|end=1645|CONC
21559013|pst|C1539876^C3813590^C1152487|start=1652|end=1655|GENE^PHYS
21559013|associated with|C0332281|start=1661|end=1676|CONC
21559013|p53|C0079419^C1705526|start=1695|end=1698|GENE
21559013|overexpression|C1514559|start=1699|end=1713|PHYS
21559013|cases|C1533148^C0868928|start=1728|end=1733|CONC
21559013|increase|C0442805|start=1750|end=1758|CONC
21559013|disease-free survival|C0242793|start=1785|end=1806|CONC
21559013|time|C0040223^C1548318^C1547403^C3541383|start=1807|end=1811|CONC
21559013|no change|C1548568|start=1828|end=1837|CONC
21559013|reduced|C0392756|start=1843|end=1850|CONC
21559013|number|C1554106^C0449788^C0237753|start=1851|end=1857|CONC
21559013|survival|C0038952^C0220921|start=1875|end=1883|ACTI^CONC
21559013|difference|C1705242^C1705241|start=1884|end=1894|CONC
21559013|changes|C0392747^C0443172|start=1931|end=1938|CONC
21559013|aldh1|C1412333|start=1942|end=1947|GENE
21559013|tumour cell|C0431085|start=1949|end=1960|ANAT
21559013|population|C0032659|start=1961|end=1971|CONC
21559013|received|C1514756|start=1992|end=2000|CONC
21559013|ac regimen|C1879503|start=2001|end=2011|PROC
21559013|conclusion|C1707478|start=2013|end=2023|CONC
21559013|present|C0150312^C0449450|start=2029|end=2036|CONC
21559013|study|C0947630^C2603343^C0557651^C0008972^C1705923^C1880229|start=2037|end=2042|PROC^OBJC^CONC
21559013|provides|C0359589|start=2043|end=2051|OBJC
21559013|clinical|C1611832^C1555900^C1608518^C3272565^C0205210|start=2056|end=2064|CONC
21559013|evidence|C0332120|start=2065|end=2073|CONC
21559013|breast cancer|C0006142^C0678222|start=2100|end=2113|DISO
21559013|associated with|C0332281|start=2141|end=2156|CONC
21559013|tumour progression|C0178874|start=2157|end=2175|DISO
21559013|need for|C0686904|start=2193|end=2201|CONC
21559013|targeting|C0599894^C1521840|start=2202|end=2211|PHYS^CONC
21559013|breast cancer|C0006142^C0678222|start=2227|end=2240|DISO
21559013|therapeutics|C0039796|start=2241|end=2253|PROC
